These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 12498015)
21. Pharmacological profile and clinical characteristics of frovatriptan in the acute treatment of migraine: introduction. Silberstein SD Headache; 2002 Apr; 42 Suppl 2():S45-6. PubMed ID: 12028319 [No Abstract] [Full Text] [Related]
22. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination. Cady RK; Banks J; Jones BA; Campbell J Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164 [TBL] [Abstract][Full Text] [Related]
23. Frovatriptan: new drug. Migraine attacks: an unnecessary triptan. Less effective than sumatriptan, but more adverse effects. Prescrire Int; 2008 Jun; 17(95):106. PubMed ID: 18623914 [No Abstract] [Full Text] [Related]
24. Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline. Kelman L; Harper SQ; Hu X; Campbell JC Curr Med Res Opin; 2010 Sep; 26(9):2097-104. PubMed ID: 20642390 [TBL] [Abstract][Full Text] [Related]
25. Frovatriptan, a probable cause of coronary vasoconstriction. Hadjiloizou N; Rakhit R Int J Clin Pract; 2008 Jul; 62(7):1121-2. PubMed ID: 18564276 [No Abstract] [Full Text] [Related]
27. Frovatriptan approved as migraine treatment. Thompson CA Am J Health Syst Pharm; 2002 Jan; 59(2):116, 120. PubMed ID: 11826560 [No Abstract] [Full Text] [Related]
28. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study. Spierings EL; Keywood C Pain Med; 2009; 10(4):633-8. PubMed ID: 19453958 [TBL] [Abstract][Full Text] [Related]
29. When to use frovatriptan in migraine? Tfelt-Hansen PC J Headache Pain; 2011 Jun; 12(3):393-4; author reply 395-6. PubMed ID: 21512776 [No Abstract] [Full Text] [Related]
30. Going the distance. New pain treatment provide longer stronger relief. D'Arcy Y Adv Nurse Pract; 2007 Jun; 15(6):32-6; quiz 37. PubMed ID: 19999007 [No Abstract] [Full Text] [Related]
31. Early treatment in migraine: how strong is the current evidence? Gendolla A Cephalalgia; 2008 Sep; 28 Suppl 2():28-35. PubMed ID: 18715330 [TBL] [Abstract][Full Text] [Related]
32. [Also keeps long migraine attacks in check. A new triptan]. MMW Fortschr Med; 2003 Feb; 145(6):61. PubMed ID: 12619371 [No Abstract] [Full Text] [Related]
33. [Almotriptan. One more triptan for migraines]. Taéron C Rev Infirm; 2004 Jun; (102):43-4. PubMed ID: 15984736 [No Abstract] [Full Text] [Related]
35. Pharmacokinetics of frovatriptan in adolescent migraineurs. Elkind AH; Wade A; Ishkanian G J Clin Pharmacol; 2004 Oct; 44(10):1158-65. PubMed ID: 15342617 [TBL] [Abstract][Full Text] [Related]
36. Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine. Sandrini G; Dahlöf CG; Mathew N; Nappi G Int J Clin Pract; 2005 Nov; 59(11):1356-65. PubMed ID: 16236092 [TBL] [Abstract][Full Text] [Related]
37. [Bonus-malus regulations in the framework of the AVWG guideline-suitable migraine therapy are possible]. MMW Fortschr Med; 2007 May; 149 Suppl 2():102-3. PubMed ID: 17724980 [No Abstract] [Full Text] [Related]